A Phase I Study Evaluating the Safety, Tolerability, PK and PD in Healthy Chinese Volunteers

NCT03971916 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Chinese Volunteers

Interventions

DRUG: HBM9161(HL161BKN)
DRUG: Placebo

Sponsor

Harbour BioMed (Guangzhou) Co. Ltd.